COVID-19 vaccines have been developed at an unprecedented rate. Over 50 vaccines are in human trials. Several vaccines have received emergency / limited authorization for use in several countries. Several countries have commenced vaccination of priority groups, and many more are expected to commence in coming months. Almost all countries are in the process of procuring, approving and planning their distribution and administration of vaccine. Meanwhile many vaccine candidates continue to be developed and tested.
On a country-by-country basis, MedAire through its group International SOS is continuing to identify the additional support that can be provided to our customers in facilitating, within the rules established by the national authorities, vaccine access, its distribution and/or the vaccination of the employees for our clients. Such support ensures the “readiness” of employers once relevant vaccine(s) become available in a given location. This overview includes all vaccines in Phases 2/3, Phase 3 and Phase 4 trials.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.